Puma Biotechnology Inc (PBYI)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

10880 WILSHIRE BLVD. LOS ANGELES, CA 90024

Puma Biotechnology, Inc. is a development-stage biopharmaceutical company. The Company develops novel therapeutics for the treatment of various forms of cancer. Puma focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use.

Data based on most recent fiscal year report
Market Cap381.418 Million Shares Outstanding38.96 Million Avg Volume1.841 Million
1-Yr BETA vs S&P TR1.666 Current Ratio3.02 Quick Ratio2.99
View SEC Filings from PBYI instead.

View recent insider trading info

Funds Holding PBYI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PBYI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

9.5 Thousand total shares from 7 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MILLER MICHAEL PATRICK EVP, US COMMERCIAL

  • Officer
28,071 2020-01-13 1

O'DOWD HUGH PRESIDENT & CEO

  • Officer
  • Director
785,868 2020-01-12 2

BRYCE RICHARD PAUL SEE REMARKS

  • Officer
34,939 2020-01-02 14

AUERBACH ALAN H PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
4,181,031 2020-01-02 14

HUNT DOUGLAS M SEE REMARKS

  • Officer
11,284 2020-01-02 3

ADAGE CAPITAL PARTNERS GP, L.L.C.

ADAGE CAPITAL PARTNERS, L.P.

ADAGE CAPITAL ADVISORS, L.L.C.

ATCHINSON ROBERT

GROSS PHILLIP

  • 10% Owner
7,828,550 2019-11-20 0

MILLER ANN CALBY

  • Director
0 2019-11-12 2

SENDEROWICZ ADRIAN CHIEF MEDICAL OFFICER

15,884 2019-11-06 1

LO STEVEN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-10-21 2

MOYES JAY M

  • Director
3,961 2019-07-26 1

MALLEY THOMAS

  • Director
0 2019-06-25 0

WILSON TROY EDWARD

  • Director
26,145 2019-06-10 1

ZAVRL FRANK

  • Director
934,321 2019-06-10 1

EYLER CHARLES R SEE REMARKS

  • Officer
31,957 2019-02-04 1

NOUGUES MAXIMO F CHIEF FINANCIAL OFFICER

  • Officer
0 2018-11-11 0

CHARNAS ROBERT SEE REMARKS

  • Officer
0 2017-02-16 0

PHILLIPS RICHARD BENTON SEE REMARKS

  • Officer
0 2016-04-15 0

SIDDIQI FARAAZ

  • FORMER SECRETARY AND DIRECTOR
No longer subject to file 2011-10-04 0

MUNJAL KAPIL

  • FORMER DIRECTOR
No longer subject to file 2011-10-04 0

JOHNSON ROBERT ANDREW

  • FORMER PRESIDENT AND DIRECTOR
No longer subject to file 2011-10-04 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BRYCE RICHARD PAUL - Officer SEE REMARKS

2020-01-02 S 2 $8.36 d 36,453 34,939.00 direct

AUERBACH ALAN H - Director - Officer - > 10% Owner PRESIDENT AND CEO

2020-01-02 S 43 $8.32 d 4,187,004 4,181,031.00 direct

HUNT DOUGLAS M - Officer SEE REMARKS

2020-01-02 S 1,405 $8.43 d 11,284 11,284.00 direct

BRYCE RICHARD PAUL - Officer SEE REMARKS

2020-01-02 S 1,514 $8.40 d 34,939 34,939.00 direct

AUERBACH ALAN H - Director - Officer - > 10% Owner PRESIDENT AND CEO

2020-01-02 S 5,973 $8.39 d 4,181,031 4,181,031.00 direct

AUERBACH ALAN H - Director - Officer - > 10% Owner PRESIDENT AND CEO

2019-12-02 S 455 $10.33 d 4,187,047 4,187,047.00 direct

BRYCE RICHARD PAUL - Officer SEE REMARKS

2019-12-02 S 83 $10.34 d 36,455 36,455.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments